文献速递眼整形与眼眶眼底病与葡萄膜炎

绞股蓝皂苷通过抗炎与抗纤维化保护Graves眼病眼眶成纤维细胞

Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

该研究探讨绞股蓝皂苷(Gyps)对Graves眼病(GO)患者眼眶成纤维细胞(OFs)炎症和纤维化的作用,采用生物信息学分析与体外实验,发现Gyps可下调IL-1β诱导的炎症因子和TGF-β1诱导的纤维化介质,并抑制TLR4/NF-κB和TGF-β1/SMAD2/SMAD4信号通路活化,提示Gyps对GO炎症和纤维化具有治疗潜力。

要点

  • Gyps下调IL-1β诱导的GO眼眶成纤维细胞炎症因子表达。
  • Gyps下调TGF-β1诱导的GO眼眶成纤维细胞纤维化介质表达。
  • Gyps抑制TLR4/NF-κB和TGF-β1/SMAD2/SMAD4信号通路活化。

核心结论

  • Gyps可保护GO来源的眼眶成纤维细胞免受IL-1β诱导的炎症和TGF-β1诱导的纤维化,提示其对GO炎症和纤维化可能具有治疗潜力。

研究设计与样本

  • 研究采用生物信息学分析筛选与Gyps功能相关的富集基因和信号通路,并从GO患者眼眶结缔组织培养OFs进行体外实验。
  • 采用Cell Counting Kit-8 assay评估OF增殖,采用RT-qPCR、ELISA和Western blotting评估Gyps对IL-1β诱导炎症和TGF-β1诱导纤维化的影响。

主要发现

  • 筛选出8个炎症相关靶基因和9个纤维化相关靶基因,分别主要富集于炎症和纤维化相关通路。
  • Gyps下调了IL-1β诱导的OFs炎症细胞因子上调和TGF-β1诱导的OFs纤维化介质上调。
  • Gyps降低了GO OFs中Toll样受体4/核因子-κB信号和TGF-β1/SMAD2/SMAD4信号的活化。

临床怎么用

  • Gyps可能作为针对GO眼眶炎症和纤维化的潜在治疗选择,但需进一步临床研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the effect of Gypenosides (Gyps) on the inflammation and fibrosis in orbital fibroblasts (OFs) in Graves ophthalmopathy (GO). METHODS: Bioinformatics analyses were performed to identify the enriched genes and signaling pathways related to Gyps function. For ex vivo experiments, OFs were cultured from orbital connective tissues from patients with GO. OF proliferation was estimated by Cell Counting Kit-8 assay. Effects of Gyps treatment on interleukin (IL)-1β-induced inflammation and transforming growth factor-β1 (TGF-β1)-induced fibrosis were evaluated by real-time quantitative PCR (RT-qPCR), enzyme-linked immunosorbent assay (ELISA), and Western blotting. OFs were treated with IL-1β or TGF-β1 in the absence or presence of Gyps pretreatment, and the levels of related mRNA or proteins were evaluated by RT-qPCR or ELISA. RESULTS: Eight inflammation-related target genes and nine fibrosis-related target genes were screened out. These genes were mainly enriched in pathways corresponding to inflammation and fibrosis, respectively. IL-1β-induced upregulation of inflammatory cytokines, and TGF-β-induced upregulation of fibrotic mediators in OFs were downregulated by Gyps. Moreover, Gyps reduced the activation of Toll like receptors 4/nuclear factor-κ B signaling and TGF-β1/SMAD2/SMAD4 signaling in GO OFs. CONCLUSIONS: Gyps could protect GO-derived OFs against IL-1β-induced inflammation and TGF-β1-induced fibrosis. Thus Gyps might have therapeutic potential on inflammation and fibrosis in GO.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Li H, Ma C, Liu W, et al. Gypenosides Protect Orbital Fibroblasts in Graves Ophthalmopathy via Anti-Inflammation and Anti-Fibrosis Effects. Invest Ophthalmol Vis Sci. 2020. PMID: 32462203. doi:10.1167/iovs.61.5.64

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。